Terminated PHASE3 INTERVENTIONAL 2-arm NCT01900327

Neoadjuvant Treatment in Resectable Pancreatic Cancer (NEOPA)

Sequential Neoadjuvant Chemoradiotherapy (CRT) Followed by Curative Surgery vs. Primary Surgery Alone for Resectable, Non-metastasized Pancreatic Adenocarcinoma

Sponsor: Hannover Medical School

Conditions Pancreatic Cancer

Interventions External Beam Radiation Gemcitabine adjuvant Gemcitabine neoadjuvant Surgery

Updated 10 times since 2017 Last updated: May 4, 2018 Started: Feb 28, 2014 Primary completion: Nov 22, 2016 Completion: Jul 31, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Recruitment failure

Other terminated trials from Hannover Medical School

See all terminations from Hannover Medical School

Other Pancreatic Cancer trials with similar outcome

Browse all Pancreatic Cancer trials

A PHASE3 clinical study on Pancreatic Cancer, this trial is terminated or withdrawn. The trial is conducted by Hannover Medical School and has accumulated 10 data snapshots since 2014. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

Change History

10 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE3
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Nov 2022 — Jul 2024 [monthly]

Terminated PHASE3
Feb 2021 — Nov 2022 [monthly]

Terminated PHASE3

▶ Show 5 earlier versions

Jan 2021 — Feb 2021 [monthly]

Terminated PHASE3
Dec 2020 — Jan 2021 [monthly]

Terminated PHASE3
Nov 2020 — Dec 2020 [monthly]

Terminated PHASE3
Jun 2018 — Nov 2020 [monthly]

Terminated PHASE3

Status: Recruiting → Terminated
Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE3

First recorded

Feb 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hannover Medical School
Heidelberg University
Klinikum Darmstadt
Klinikum Stuttgart
Ludwig-Maximilians - University of Munich
SRH Wald-Klinikum Gera GmbH
St. Josef Hospital Bochum
Staedtisches Klinikum Karlsruhe
Technical University of Munich
University Hospital Augsburg
University Hospital Freiburg
University Hospital Regensburg
University Hospital Schleswig-Holstein
University of Jena
University of Rostock
Universität des Saarlandes
Universitätsklinikum Hamburg-Eppendorf

Data source: Universitätsklinikum Hamburg-Eppendorf

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Augsburg, Germany , Bochum, Germany , Darmstadt, Germany , Freiburg im Breisgau, Germany , Gera, Germany , Hamburg, Germany , Hanover, Germany , Heidelberg, Germany , Homburg, Germany , Jena, Germany and 6 more locations